DME Alliance Incorporated, 5012 Medical Center Circle, Allentown, USA (e-mail,
Cytotechnology. 2003 May;42(1):21-33. doi: 10.1023/A:1026103405618.
Equipment design is frequently recognized as a key component in the success of GMP biologics manufacturing, but is not always implemented with full appreciation of the processing implications. In the case of mammalian cell culture, there are some recognized issues and risks that develop when transitioning to a large scale of operation. The developing demand for cell culture production capacity in the biopharmaceutical industry has led to a progressive increase in the scale of operation in the last decade. This review will provide a high level summary of the documented process difficulties unique to serum-free large scale (LS) cell culture, analyze the engineering constraints typical of these processes, and suggest some practical equipment design considerations to enhance the productivity, reliability and operability of such systems under GMP manufacturing conditions. A systems approach will be used to establish a good LS bioreactor design practice, providing a discussion on gas distribution, agitation, vessel design, SIP/CIP and control issues.
设备设计通常被认为是 GMP 生物制品生产成功的关键因素,但在实施过程中并不总是充分考虑到加工的影响。就哺乳动物细胞培养而言,在向大规模生产过渡时,会出现一些公认的问题和风险。生物制药行业对细胞培养生产能力的需求不断增长,导致过去十年的生产规模不断扩大。本文将对无血清大规模(LS)细胞培养特有的、有文献记录的工艺难点进行概述,分析这些工艺的典型工程限制,并提出一些实用的设备设计注意事项,以提高此类系统在 GMP 生产条件下的生产力、可靠性和可操作性。本文将采用系统方法来建立良好的 LS 生物反应器设计实践,讨论气体分布、搅拌、容器设计、SIP/CIP 和控制问题。